Growth Model Portfolio Wealth creation through sensible investing Sat, 13 Jun 2026 20:54:27 +0000 en-US hourly 1 https://growth.rccapitalmanagement.com/wp-content/uploads/2025/07/cropped-Logo-32x32.jpg Growth Model Portfolio 32 32 Portfolio update: 15.06.26 (additional transaction) https://growth.rccapitalmanagement.com/2026/06/portfolio-update-15-06-26-additional-transaction/ Sat, 13 Jun 2026 20:54:24 +0000 https://growth.rccapitalmanagement.com/?p=7649 Please note the following transaction is in addition to the one posted yesterday Buy Rategain Travel Technologies Ltd (NSE: RATEGAIN) upto 850: 3% position after the transaction Reason for new position Detailed note on the company can be downloaded from here The cash level in the portfolio will be 17.8% after the above transaction Copyright

The post Portfolio update: 15.06.26 (additional transaction) appeared first on Growth Model Portfolio.

]]>
Please note the following transaction is in addition to the one posted yesterday

Buy Rategain Travel Technologies Ltd (NSE: RATEGAIN) upto 850: 3% position after the transaction

Reason for new position

Detailed note on the company can be downloaded from here

The cash level in the portfolio will be 17.8% after the above transaction


Copyright © R C Capital Management. All rights reserved.

RC Capital Management is a partnership firm registered with SEBI as an Investment Adviser (Registration no. INA000004088). Advisory services are provided by the Investment Advisory Department. This should not be considered as an offer to buy or sell any securities. RC Capital Management and its partners and associates will not be liable or responsible for any direct or indirect loss or liability incurred to any user on account of actions taken or decisions made by the user based of the information, views and analysis provided in this newsletter. Past performance does not guarantee future results. The information and data mentioned herein are from reliable source, but RC Capital Management does not warrant its completeness and accuracy. This information is made available for personal and non-commercial use only. Use of the information is at user’s own risk. Any act of copying, reproducing or distributing this newsletter, whether wholly or in part, for any purpose without the permission of RC Capital Management is strictly prohibited and will be considered as copyright infringement. As a condition to accessing the contents of this newsletter, you agree to the terms of use of the website

RC Capital Management – SEBI registered Investment Advisor
Type of Registration: Non-Individual Reg. No.: INA000004088, Valid till: Perpetual
Enlistment ID with IAASB – 1329
Address: B-101, Chinar Soc., Behind Subway, Kothrud, Pune-411038 +91 88060 58625
Principal Officer – Kedar Ghaisas (91-8806058625 / admin@rccapitalmanagement.com)
Compliance Officer – Praveen Nagaraja (91-9620044311 / praveen.nagaraj@rccapitalmanagement.com)
Corresponding SEBI Regional Office – SEBI Bhavan BKC, Plot No.C4-A, ‘G’ Block, Bandra-Kurla Complex, Bandra (East), Mumbai – 400051

Investments in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI, Enlistment of IA with IAASB and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

The post Portfolio update: 15.06.26 (additional transaction) appeared first on Growth Model Portfolio.

]]>
Portfolio update: 15.06.26 https://growth.rccapitalmanagement.com/2026/06/portfolio-update-15-06-26/ Sat, 13 Jun 2026 07:19:28 +0000 https://growth.rccapitalmanagement.com/?p=7645 We have 3 transactions as below Buy PRIVI SPECIALITY CHEMICALS LTD (NSE:PRIVISCL) @ 3450 upto 5% of the portfolio As it is not possible to get an exact price in real trade, the buy price range is 3600 or lower. The fair value of the company has been adjusted to 3600 We are raising the position

The post Portfolio update: 15.06.26 appeared first on Growth Model Portfolio.

]]>
We have 3 transactions as below

Buy PRIVI SPECIALITY CHEMICALS LTD (NSE:PRIVISCL) @ 3450 upto 5% of the portfolio

As it is not possible to get an exact price in real trade, the buy price range is 3600 or lower. The fair value of the company has been adjusted to 3600

We are raising the position size as the company continues to execute in spite of cost headwinds. The JV is now at break even and the new capacities should enable the management to meet its 20% growth target

Please note if you currently do not have any position in Privi Speciality Chemicals Limited, you can initiate the position as per above.

Buy Viyash scientific LTD (NSE: VIYASH) @ 250 upto 4% of the portfolio

As it is not possible to get an exact price in real trade, the buy price range is 260 or lower. The fair value of the company has been adjusted to 260

We are raising the position as the company continues to execute on its plans to expand into animal health formulations, developing the CDMO business and finally have deleveraged the balance to invest further in the business

Please note if you currently do not have any position in Viyash scientific Limited, you can initiate the position as per above.

Sell Sagility Ltd (NSE:SAGILITY) at CMP (No position after the sale)

Reason for sale

I am going to address the inevitable question on why sell at a loss – should we wait to see how this position plays out?

Let me dive into the company specific reasons first

The company provides business process outsourcing by taking on repetitive tasks of a healthcare payer and executing the same efficiently from low-cost locations. This business model is now seen by the market as facing headwinds from developments in AI

The market has a concern that these tasks can be executed by AI agents at fraction of the cost. Healthcare is a highly regulated industry where a company cannot casually implement a new system without the necessary privacy and governance controls. Sagility could become a partner in this transformation as it has deep industry knowledge

In the recent investor day meeting, the company showcased how they are developing solutions using agentic AI to enable this migration with their clients. This would allow them to use this disruption to their benefit

The above are the pros of maintaining the position. The counter point is that even as the company enables this migration to automated workflows, it will face a headwind to its topline and eventually to its core business model

I was sanguine about this risk for quite some time till I read the following point in the recent conference call transcript

The above trend is concerning and as model gets better, this risk could accelerate. It is quite possible that the company will come out fine at the end of this transition in a few years’ time.

In the interim, topline and profits could compress further and that will also lead to further reduction in valuations – aka double impact

Why take this loss ?

We have repeated this several times in the past. We constantly change our mind, especially when faced with new facts: read this post here. Could we have done it sooner? Yes, we could have but then hindsight is always 20/20

Our focus is to perform at the portfolio level and not fixate on whether we had to sell some positions at a loss. If we manage to size up on our winners and control the downside on the losers, we will do well in the long run which we have.

Can this position turn around and do well soon? sure it can. Just like each buy is not correct 100% of times, a sell may not be the right decision each time. Unless we can think in terms of probability and risk reward, making tough decisions will be painful and you will be disappointed

In doing so you will miss the forest for the trees (fixate on individual position and ignore the portfolio level performance). Unfortunately, we often get emails where some subscribers are upset on taking a loss

This emotion is understandable – most investors feel the same way. But if we act like the average investor, then our results will also be average. Our job as your advisor is to nudge you to make uncomfortable decisions which are painful in the short run but work out in the long run.

Copyright © R C Capital Management. All rights reserved.

RC Capital Management is a partnership firm registered with SEBI as an Investment Adviser (Registration no. INA000004088). Advisory services are provided by the Investment Advisory Department. This should not be considered as an offer to buy or sell any securities. RC Capital Management and its partners and associates will not be liable or responsible for any direct or indirect loss or liability incurred to any user on account of actions taken or decisions made by the user based of the information, views and analysis provided in this newsletter. Past performance does not guarantee future results. The information and data mentioned herein are from reliable source, but RC Capital Management does not warrant its completeness and accuracy. This information is made available for personal and non-commercial use only. Use of the information is at user’s own risk. Any act of copying, reproducing or distributing this newsletter, whether wholly or in part, for any purpose without the permission of RC Capital Management is strictly prohibited and will be considered as copyright infringement. As a condition to accessing the contents of this newsletter, you agree to the terms of use of the website

RC Capital Management – SEBI registered Investment Advisor
Type of Registration: Non-Individual Reg. No.: INA000004088, Valid till: Perpetual
Enlistment ID with IAASB – 1329
Address: B-101, Chinar Soc., Behind Subway, Kothrud, Pune-411038 +91 88060 58625
Principal Officer – Kedar Ghaisas (91-8806058625 / admin@rccapitalmanagement.com)
Compliance Officer – Praveen Nagaraja (91-9620044311 / praveen.nagaraj@rccapitalmanagement.com)
Corresponding SEBI Regional Office – SEBI Bhavan BKC, Plot No.C4-A, ‘G’ Block, Bandra-Kurla Complex, Bandra (East), Mumbai – 400051

Investments in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI, Enlistment of IA with IAASB and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

The post Portfolio update: 15.06.26 appeared first on Growth Model Portfolio.

]]>
Model Portfolio https://growth.rccapitalmanagement.com/2026/06/model-portfolio-2/ Thu, 11 Jun 2026 09:09:27 +0000 http://portfolio.rcfunds.com/?p=184 Portfolio status as of 31.05.2026 Current amount and Gain/loss number for the portfolio in the above table  includes dividends declared. To understand the above table further , download the portfolio explanation document. To download detailed analysis for each stock , please refer to the stock analysis page. If you need to build your personal portfolio,

The post Model Portfolio appeared first on Growth Model Portfolio.

]]>
Portfolio status as of 31.05.2026
Stock nameQtyCost priceInvest amtCurrent priceCurrent amtGain/ loss% currentResearch report
BANK OF INDIA LIMITED (XNSE:BANKINDIA)760013199560014010652417%4.20%PDF REPORT
SAGILITY LIMITED (XNSE:SAGILITY)136005270720041558144-21%2.20%PDF REPORT
CEMINDIA PROJECTS LIMITED (XNSE:CEMPRO)16652884795201,0711783465272%7.00%PDF REPORT
NARAYANA HRUDAYALAYA LIMITED (XNSE:NH)7808236419401,8941477320130%5.80%PDF REPORT
Nippon India ETF Nifty 50 BeES (XNSE:NIFTYBEES)4150252104580026811112876%4.30%REPORT
THYROCARE TECHNOLOGIES LIMITED (XNSE:THYROCARE)38552821087110506195178780%7.60%PDF REPORT
APAR INDUSTRIES LIMITED (XNSE:APARINDS)115211624334013,1181508570520%5.90%PDF REPORT
NUVAMA WEALTH MANAGEMENT LIMITED (XNSE:NUVAMA)86010318866601,555133695651%5.20%PDF REPORT
TALBROS AUTOMOTIVE COMPONENTS LIMITED (XNSE:TALBROAUTO)260018648360034589791086%3.50%PDF REPORT
JUBILANT INGREVIA LIMITED (XNSE:JUBLINGREA)12256467913506467915950%3.10%PDF REPORT
PRIVI SPECIALITY CHEMICALS LIMITED (XNSE:PRIVISCL)30522606893003,25599283644%3.90%PDF REPORT
BAJAJ HOLDINGS & INVESTMENT LIMITED. (XNSE:BAJAJHLDNG)8014217113736010,361828880-27%3.20%REPORT
GOODLUCK INDIA LIMITED (XNSE:GOODLUCK)92010109292001,295119176828%4.70%PDF REPORT
Viyash Scientific Limited (XNSE:VIYASH)370020575850026296917828%3.80%PDF REPORT
ICICI BANK LIMITED (XNSE:ICICIBANK)85011749979001,25610679407%4.20%PDF REPORT
S.J.S. ENTERPRISES LIMITED (XNSE:SJS)8758747647502,1051842050141%7.20%PDF REPORT
AARTI PHARMALABS LIMITED (XNSE:AARTIPHARM)147555882305063393404413%3.70%PDF REPORT
Total134621802030897050.90%79.40%
Net cash525537020.60%
Current value20307045
Total value25562415

Current amount and Gain/loss number for the portfolio in the above table  includes dividends declared. To understand the above table further , download the portfolio explanation document.

To download detailed analysis for each stock , please refer to the stock analysis page.

If you need to build your personal portfolio, please refer to the portfolio creation note

To review  portfolio performance and past transactions, refer to portfolio performance page.

Copyright © R C Capital Management. All rights reserved.

RC Capital Management is a partnership firm registered with SEBI as an Investment Adviser (Registration no. INA000004088). Advisory services are provided by the Investment Advisory Department. This should not be considered as an offer to buy or sell any securities. RC Capital Management and its partners and associates will not be liable or responsible for any direct or indirect loss or liability incurred to any user on account of actions taken or decisions made by the user based of the information, views and analysis provided in this newsletter. Past performance does not guarantee future results. The information and data mentioned herein are from reliable source but RC Capital Management does not warrant its completeness and accuracy. This information is made available for personal and non-commercial use only. Use of the information is at user’s own risk. Any act of copying, reproducing or distributing this newsletter, whether wholly or in part, for any purpose without the permission of RC Capital Management is strictly prohibited and will be considered as copyright infringement. As a condition to accessing the contents of this newsletter, you agree to the terms of use of the website

RC Capital Management – SEBI registered Investment Advisor
Type of Registration: Non-Individual Reg. No. : INA000004088, Valid till : Perpetual, Enlistment Id with IAASB – 1329
Address : B-101, Chinar Soc., Behind Subway, Kothrud, Pune-411038 +91 88060 58625
Principal Officer – Kedar Ghaisas ( 91-8806058625 / admin@rccapitalmanagement.com), Compliance Officer – Praveen Nagaraj ( 91-9620044311 /praveen.nagaraj@rccapitalmanagement.com)
Grievance Officer – Kedar Ghaisas ( 91-8806058625 / admin@rccapitalmanagement.com)
Corresponding SEBI Regional Office – SEBI Bhavan BKC, Plot No.C4-A, ‘G’ Block, Bandra-Kurla Complex, Bandra (East), Mumbai – 400051

Investments in securities market are subject to market risks. Read all the related documents carefully before investing

Registration granted by SEBI, enlistment with IAASB and certification from NISM in no way guarantee performance of the IA or provide any assurance of returns to investors.

The post Model Portfolio appeared first on Growth Model Portfolio.

]]>